| Senores Pharmaceuticals Ltd |
|
|
| Initial public offering of 14,887,723 equity shares of face value of Rs. 10 each ("Equity Shares") of Senores Pharmaceuticals Limited ("The Company" or the "Issuer") for cash at a price of Rs. 391 per equity share (including a share premium of Rs. 381 per equity share) ("Offer Price") aggregating to
Rs. 582.11 crores (the "Offer"). The offer comprises of a fresh issue of 12,787,723 equity shares by the company aggregating to Rs. 500.00 crores (the "Fresh Issue") and an offer for sale of 2,100,000 equity shares (the "Offered Shares") aggregating to Rs. 82.11 crores (the "Offer for Sale"), comprising 250,000 equity shares aggregating to Rs. 9.78 crores by Swapnil Jatinbhai Shah, 550,000 equity shares aggregating to Rs. 21.51 crores by Ashokkumar Vijaysinh Barot, 300,000 equity shares aggregating to Rs. 11.73 crores by Sangeeta Mukur Barot and 1,000,000 equity shares aggregating to
Rs. 39.10 crores by Prakash M Sanghvi (the "Selling Shareholders"). The offer shall constitute 32.33 % of the post-offer paid-up equity share capital of the company.
The offer includes a reservation of 75,000 equity shares, aggregating to
Rs. 2.93 crores constituting 0.16% of the post-offer paid-up equity share capital, for subscription by eligible employees ("Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer".
The face value of the equity shares is Rs. 10 each and the offer price is 39.10 times the face value of the equity shares.
|
| Issue |
Money Payable On |
| Opened On |
Closed On |
Offer Price |
Application |
| 20-Dec-24 |
24-Dec-24 |
₹ 391.00 |
₹ 391.00 |
| Minimum Application for shares in Nos :38 Further Multiples of :38 |
| |
|
Lead Managers to the Issue |
| Project Cost |
₹ 457.81 Cr |
| Ambit Pvt Ltd | | Equirus Capital Pvt Ltd | | Nuvama Wealth Management Ltd |
|
| Project Financed through Current Offer |
₹ 582.11 Cr |
|
| Post Issue Equity Share Capital |
₹ 46.05 Cr |
|
| Face Value |
₹ 10 |
|
|